Reversible Acute Blindness in Suspected Metformin-Associated Lactic Acidosis

Reversible Acute Blindness in Suspected Metformin-Associated Lactic Acidosis:

Publication date: Available online 4 October 2019

Source: The Journal of Emergency Medicine

Author(s): Seung Ryu, Se-Kwang Oh, Seung-Ha Son, Won-Joon Jeong, Yeon-Ho You, Young-Rok Ham

Abstract

Background

Metformin is commonly used for the treatment of type 2 diabetes mellitus. Renal insufficiency is one of the contraindications for its use. Inadvertent prescription in patients with renal insufficiency may lead to metformin-associated lactic acidosis (MALA), which is associated with a high risk of mortality. Consequently, the early recognition and management of MALA is essential.

Case Report

We present the case of a 68-year-old man who had reversible blindness resulting from severe lactic acidosis. On presentation, he was alert, oriented, and had no complaints except mild abdominal discomfort and blindness. He denied any history of trauma or drug abuse. The results of the laboratory studies showed severe metabolic acidosis with a high anion gap and increased levels of serum creatinine. There were no predisposing ocular or neurologic lesions that could have induced the blindness. Although the blood levels of methanol, ethanol, and metformin were not estimated, correction of acidosis and hemodialysis led to a complete recovery.

Why Should an Emergency Physician Be Aware of This?

Rarely, transient blindness may occur in patients with fatal severe metabolic acidosis. Evaluation for the presence of metabolic acidosis and a detailed medical history are essential in the management of acute blindness in such patients.